For example, ZFP36L1 decreases numerous oncogenic transcripts that are involved in the cell cycle and hypoxic signaling pathways in bladder cancer, leading to inhibition of hypoxic adaptation, metabolism, angiogenesis, and cell cycle progression [8]. Here, ZFP36L1 is linked to urinary bladder carcinoma.